Upgrade to SI Premium - Free Trial

PolyPid to present surgical infection data at medical conference

April 28, 2026 8:30 AM
PolyPid Ltd. (NASDAQ: PYPD) announced it will present data from its SHIELD II Phase 3 trial at the Surgical Infection ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA